Blend Labs, Inc.
NYSE:BLNDSoftware - Application
-$0.03 today
- Market cap
- $218.02M
- Beta
- 1.09
- P/E (TTM)
- -71.2
- EPS (TTM)
- -$0.02
Volume 1.19M
Average 3.92M
BLND Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Blend Labs, Inc.NYSE: BLND
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $9.41M rose 25.2% year over year, ahead of the -11.9% change in trailing-twelve-month research & development. Sequentially, it fell 0.6% from the prior quarter. Over 3 fiscal years it compounded at -38.0% a year.
Context
- Research & development amounted to 26.6% of revenue in FY2025, down 1.9 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +25.2% holds above the trailing-twelve-month pace of -11.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 32.84M USD
- Year-over-year change
- -28.7%
- 4-year CAGR
- -22.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.84M | -28.7% |
| FY2024 | 2024-12-31 | 46.09M | -43.5% |
| FY2023 | 2023-12-31 | 81.59M | -40.9% |
| FY2022 | 2022-12-31 | 138.09M | +49.8% |
| FY2021 | 2021-12-31 | 92.22M | — |
Research & Development vs competitors
How BLND compares with its peers on the latest reported figures
- BLND's LTM Mar 2026 research & development of $34.74M is the 7th highest of the 10 companies compared; the peer median is $52.17M.
- Its year-over-year change of -11.9% is the 7th highest of 9, against a peer median of +1.4%.
- Research & development amounts to 27.2% of revenue for BLND, versus a peer median of 18.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $206.19M | -1.8% | +5.5% | 18.4% | |
| LTM Mar 2026 | $68.47M | +0.1% | -2.2% | 19.5% | |
| LTM Mar 2026 | $66.07M | +18.3% | +3.8% | 26.7% | |
| LTM Mar 2026 | $57.52M | -15.0% | +12.8% | 16.9% | |
| LTM Mar 2026 | $52.17M | +11.2% | +26.5% | 20.8% | |
| LTM Mar 2026 | $40.48M | +2.6% | -10.5% | 7.2% | |
| LTM Mar 2026 | $34.74M | -11.9% | -38.0% | 27.2% | |
LAESSEALSQ Corp | FY2025 | $12.48M | +120.4% | +72.8% | 68.4% |
| LTM Mar 2026 | $2.65M | — | — | 2.8% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding BLND) | $52.17M | +1.4% | +5.5% | 18.4% | |
Competitors are the stored peer set for BLND. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 234.5M | 235.2M | 156.85M | 162.02M | 123.59M |
| Cost of Revenue | 118.51M | 145.55M | 75.71M | 71.48M | 32.42M |
| Gross Profit | 115.99M | 89.65M | 81.14M | 90.54M | 91.17M |
| Gross Margin | 49.5% | 38.1% | 51.7% | 55.9% | 73.8% |
| Research & Development | 92.22M | 138.09M | 81.59M | 46.09M | 32.84M |
| Selling, General & Admin | 212.88M | 224.37M | 130.82M | 86.61M | 79.19M |
| Operating Expenses | 313.23M | 835.83M | 237.36M | 140.16M | 112.03M |
| Depreciation & Amortization | 13.81M | 14.42M | 5.76M | 4.82M | 3.82M |
| EBITDA | (182.94M) | (726.85M) | (143.21M) | (31.74M) | 2.94M |
| EBITDA Margin | -78.0% | -309.0% | -91.3% | -19.6% | 2.4% |
| Operating Income | (197.24M) | (746.18M) | (156.22M) | (49.62M) | (20.86M) |
| Operating Margin | -84.1% | -317.3% | -99.6% | -30.6% | -16.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 11.28M | 24.79M | 30.81M | 6.75M | 0 |
| Other Income / Expenses | (10.79M) | (19.87M) | (23.56M) | 6.31M | 19.99M |
| Income Before Tax | (208.03M) | (766.05M) | (179.79M) | (43.31M) | (878K) |
| Pre-Tax Margin | -88.7% | -325.7% | -114.6% | -26.7% | -0.7% |
| Income Tax Expense | (38.89M) | (2.24M) | 94K | 109K | 249K |
| Net Income | (171.34M) | (768.61M) | (185.32M) | (49.6M) | (8.06M) |
| Net Margin | -73.1% | -326.8% | -118.2% | -30.6% | -6.5% |
| EPS (Basic) | (0.74) | (3.28) | (0.76) | (0.24) | (0.10) |
| EPS (Diluted) | (0.74) | (3.28) | (0.76) | (0.24) | (0.10) |
| Weighted Avg Shares | 230.32M | 234.16M | 245.21M | 253.92M | 258.95M |
| Weighted Avg Shares (Diluted) | 230.32M | 234.16M | 245.21M | 253.92M | 258.95M |
Blend Labs, Inc.
NYSE:BLND
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.